Literature DB >> 35360504

Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome in children is challenging like in adults.

Josef Finsterer1.   

Abstract

Entities:  

Keywords:  COVID-19; Guillain-Barre syndrome; SARS-CoV-2; Side effects; Vaccination

Year:  2022        PMID： 35360504      PMCID： PMC8958252          DOI： 10.1016/j.amsu.2022.103545

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN： 2049-0801


× No keyword cloud information.
  5 in total

1.  Diagnosis of Guillain-Barré syndrome in children and validation of the Brighton criteria.

Authors:  Joyce Roodbol; Marie-Claire Y de Wit; Bianca van den Berg; Vivienne Kahlmann; Judith Drenthen; Coriene E Catsman-Berrevoets; Bart C Jacobs
Journal:  J Neurol       Date:  2017-03-01       Impact factor: 4.849

2.  Lethal Pediatric Cerebral Vasculitis Triggered by Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:  Kelsey E Poisson; Alexander Zygmunt; Daniel Leino; Christine E Fuller; Blaise V Jones; David Haslam; Mary Allen Staat; Gwendolyn Clay; Tracy V Ting; Kristen Wesselkamper; Barbara Hallinan; Shannon Standridge; Melissa E Day; Monica McNeal; Charles B Stevenson; Marissa Vawter-Lee
Journal:  Pediatr Neurol       Date:  2021-11-12       Impact factor: 3.372

3.  Guillan barre syndrome in post Covid-19 infection in children.

Authors:  Sanae El Mezzeoui; Fatima Zahra Aftiss; Mohammed Aabdi; Houssam Bkiyar; Brahim Housni
Journal:  Ann Med Surg (Lond)       Date:  2021-06-20

4.  HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome.

Authors:  Gian Luigi Gigli; Alberto Vogrig; Annacarmen Nilo; Martina Fabris; Alessia Biasotto; Francesco Curcio; Valeria Miotti; Carlo Tascini; Mariarosaria Valente
Journal:  Neurol Sci       Date:  2020-12       Impact factor: 3.307

5.  Prevalence and Risk Factors of Neurologic Manifestations in Hospitalized Children Diagnosed with Acute SARS-CoV-2 or MIS-C.

Authors:  Ericka L Fink; Courtney L Robertson; Mark S Wainwright; Juan D Roa; Marlina E Lovett; Casey Stulce; Mais Yacoub; Renee M Potera; Elizabeth Zivick; Adrian Holloway; Ashish Nagpal; Kari Wellnitz; Theresa Czech; Katelyn M Even; Werther Brunow de Carvalho; Isadora Souza Rodriguez; Stephanie P Schwartz; Tracie C Walker; Santiago Campos-Miño; Leslie A Dervan; Andrew S Geneslaw; Taylor B Sewell; Patrice Pryce; Wendy G Silver; Jieru Egeria Lin; Wendy S Vargas; Alexis Topjian; Alicia M Alcamo; Jennifer L McGuire; Jesus Angel Domínguez Rojas; Jaime Tasayco Muñoz; Sue J Hong; William J Muller; Matthew Doerfler; Cydni N Williams; Kurt Drury; Dhristie Bhagat; Aaron Nelson; Dana Price; Heda Dapul; Laura Santos; Robert Kahoud; Conall Francoeur; Brian Appavu; Kristin P Guilliams; Shannon C Agner; Karen H Walson; Lindsey Rasmussen; Anna Janas; Peter Ferrazzano; Raquel Farias-Moeller; Kellie C Snooks; Chung-Chou H Chang; James Yun; Michelle E Schober
Journal:  Pediatr Neurol       Date:  2021-12-28       Impact factor: 3.372
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.